PROVITI's
INNOVATION
CYCLE


read more

our credo


PROVITI is a company focused on the generation and development of biotechnological research and innovations in the area of nutrition and nutracueuticals. We aim to bring these innovations to life by facilitating an effective cycle of technological transfer and licencing or marketing of the product concepts and know-how developed.

We believe that we are what we eat and that our health is directly linked to the quality and substance of our personalized nutrition.


An investment in knowledge pays the best interest.
Benjamin Franklin

what`s new?

18/02/2013

PROVITI successfully made the market launch of its first innovative nutraceutical formula – a probiotic product range based on the new proprietary strain Lactobacillus acidophilus Proviti (ССМ 8427) from our collection with in-vitro attested beneficial characteristics for the human health. The product range includes a yogurt, a yogurt drink and capsules marketed under the brand VEDA Bulgarica.


15/02/2013

The Contracting Authority of EU Operational Programme “Competitiveness”, approved for financing a second project proposal by PROVITI for the commercialization of a lyophilized synbiotic formula based on the probiotic strain Lactobacillus acidophilus Proviti under procedure “Development of innovation start-ups through support for the commercialization of innovative products, processes and services”. The project will be implemented over the next 24 months.


21/12/2012

As part of its strategy for building strategic partnerships aimed at developing an innovation ecosystem supporting the exchange of knowledge and experience and the incubation of ideas, PROVITI signed a Memorandum for Cooperation with Sofia Tech Park EAD – the company established by the Bulgarian Ministry of Economy as a flagship enterprise for the implementation of the national policy for supporting innovations.


21/12/2012

Following detailed evaluation, the Contracting Authority of EU Operational Programme “Competitiveness”, under the procedure “Development of innovations by start-up companies”, approved for financing PROVITI’s project proposal for the development of an immune system boosting bacterial formula with prophylactic and anti-inflammatory effect on the digestive tract. The project will be implemented over the next 24 months.


12/10/2012

PROVITI has further expanded its innovation partnership ecosystem by signing a Memorandum for Cooperation with the Institute of Cryobiology and Food Technology, Bulgarian Agricultural Academy (“ICFT”). PROVITI and ICFT will be cooperating in the research and development of innovative nutraceutical solutions and building physical infrastructure to support effective technological transfer process.


17/09/2012

PROVITI has expanded its innovation partnership ecosystem by signing a Memorandum for Cooperation with the Faculty of Chemistry and Pharmacy of the Sofia Universiry “St. Climent Ohridski” (“FCP”). PROVITI and FCP will be cooperating in the research and development of innovative nutraceutical solutions and building physical infrastructure to support effective technological transfer process.


06/07/2012

PROVITI filed a patent application for its new formula for an innovative probiotic product. The formula contains our proprietary strain of L. Acidophilus Proviti (registered with CCM under CCM8427), which in addition to its probiotic qualities, demonstrated through in-vitro testing that it efficiently absorbs serum cholesterol.


16/01/2012

TED - Sharing powerful stories from his anti-obesity project in Huntington, W. Va., TED Prize winner Jamie Oliver makes the case for an all-out assault on our ignorance of food. link to video